Clinics and research in hepatology and gastroenterology最新文献

筛选
英文 中文
Correspondence on “Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective study” 关于“评估暴露于SARS-CoV-2感染患者肝功能和结构的长期变化:一项前瞻性研究”的通信。
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-27 DOI: 10.1016/j.clinre.2025.102628
Hinpetch Daungsupawong , Viroj Wiwanitkit
{"title":"Correspondence on “Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: a prospective study”","authors":"Hinpetch Daungsupawong , Viroj Wiwanitkit","doi":"10.1016/j.clinre.2025.102628","DOIUrl":"10.1016/j.clinre.2025.102628","url":null,"abstract":"","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102628"},"PeriodicalIF":2.6,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of the fibrosis-3 index for predicting liver fibrosis 5 years after achieving sustained virological response in patients with chronic hepatitis C 慢性丙型肝炎患者实现持续病毒学应答后5年纤维化-3指数预测肝纤维化的效用
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-27 DOI: 10.1016/j.clinre.2025.102625
Kazuya Kariyama , Hidenori Toyoda , Takashi Kumada , Satoshi Yasuda , Yoshihiko Tachi , Takanori Hirai , Shohei Shiota , Akiko Wakuta , Kazuhiro Nouso
{"title":"Utility of the fibrosis-3 index for predicting liver fibrosis 5 years after achieving sustained virological response in patients with chronic hepatitis C","authors":"Kazuya Kariyama ,&nbsp;Hidenori Toyoda ,&nbsp;Takashi Kumada ,&nbsp;Satoshi Yasuda ,&nbsp;Yoshihiko Tachi ,&nbsp;Takanori Hirai ,&nbsp;Shohei Shiota ,&nbsp;Akiko Wakuta ,&nbsp;Kazuhiro Nouso","doi":"10.1016/j.clinre.2025.102625","DOIUrl":"10.1016/j.clinre.2025.102625","url":null,"abstract":"<div><h3>Aim</h3><div>Non-invasive tests for liver fibrosis frequently use serum aminotransferases; however, their accuracy may be influenced by hepatitis virus eradication. This study evaluated the effectiveness of the age-independent FIB-3 index in patients with chronic hepatitis C who achieved sustained virological response (SVR).</div></div><div><h3>Methods</h3><div>A total of 115 patients who achieved SVR following interferon therapy were analyzed. Liver fibrosis was assessed by biopsy before treatment and 5 years after achieving SVR. The diagnostic accuracies of the FIB-3 and FIB-4 indices were compared using Receiver Operating Characteristic (ROC) curve analysis and representative cutoff values (FIB-3:3.5, FIB-4:2.67), with a specific focus on age-stratified performance.</div></div><div><h3>Results</h3><div>Age-stratified analysis revealed distinct patterns in fibrosis index performance before and after SVR. Among patients aged ≥ 65 years, both indices demonstrated poor accuracy pre-SVR (FIB-3:0.35, FIB-4:0.29) but markedly improved post-SVR, with FIB-3 demonstrating significantly superior performance (accuracy: 0.82 vs 0.64). This improvement was primarily due to better specificity (FIB-3:0.85 vs FIB-4,0.60) while maintaining high sensitivity (0.62 vs 0.87). In patients aged &lt; 65 years, both indices exhibited modest improvement post-SVR, with no significant differences observed.</div></div><div><h3>Conclusions</h3><div>At established cutoff values, the FIB-3 index demonstrated significantly higher diagnostic performance than the FIB-4 index, particularly in patients aged ≥ 65 years who achieved SVR. These findings suggest that the FIB-3 index is a reliable tool for long-term monitoring of liver fibrosis after hepatitis C eradication.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102625"},"PeriodicalIF":2.6,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic kidney disease in isolated core antibody positive hepatitis B patients: Risk analysis from NHANES 2017–2020 study 分离的核心抗体阳性乙型肝炎患者的慢性肾脏疾病:NHANES 2017-2020研究的风险分析:HBV感染和CKD风险
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-27 DOI: 10.1016/j.clinre.2025.102627
Ke Mi , Tingdan Ye , Calvin Q. Pan
{"title":"Chronic kidney disease in isolated core antibody positive hepatitis B patients: Risk analysis from NHANES 2017–2020 study","authors":"Ke Mi ,&nbsp;Tingdan Ye ,&nbsp;Calvin Q. Pan","doi":"10.1016/j.clinre.2025.102627","DOIUrl":"10.1016/j.clinre.2025.102627","url":null,"abstract":"<div><h3>Background</h3><div>The association between isolated hepatitis B core antibody (HBcAb) positivity and chronic kidney disease (CKD) remains debated. While some studies suggest HBV infection increases CKD risk, others report inconclusive findings. This study evaluated the association between isolated HBcAb positivityand CKD in the U.S. population.</div></div><div><h3>Methods</h3><div>Data from adult participants in the NHANES 2017–2020 pre-pandemic cycle were analyzed based on prespecified eligibility criteria. Participants were categorized into isolated HBcAb positive and non-infected groups. Weighted means and percentages described participant characteristics, while logistic regression models evaluated the association between isolated HBcAb positive and CKD. Multivariate logistic regression identified CKD risk factors among isolated HBcAb positive individuals.</div></div><div><h3>Results</h3><div>Among 7,582 participants (7072 non- infected and 510 isolated HBcAb positive), CKD prevalence was higher in isolated HBcAb positive individuals (7.9 %vs. 5.2 %, <em>P</em> = 0.018). Unadjusted analyses showed isolated HBcAb positivity increased CKD risk (OR = 1.25, 95 % CI: 1.04–1.50, <em>P</em> = 0.019). However, adjusted analyses revealed an inverse association (OR = 0.76, 95 % CI: 0.60–0.98, <em>P</em> = 0.034). In isolated HBcAb positive individuals, older age (OR = 1.06, <em>P</em> = 0.017) and serum urea nitrogen (BUN) elevation (OR = 1.20, <em>P</em> = 0.001) were associated with higher CKD risk, while higher education lever reduced the risk (OR = 0.28, <em>P</em> = 0.030).</div></div><div><h3>Conclusion</h3><div>Although CKD prevalence was higher in isolated HBcAb positive patients, There was no positive association between isolated HBcAb positivity and CKD. Older age and elevated BUN levels were significantly associated with higher CKD risk, while elevated education lever reduced the risk. These findings highlight the needs for individualized monitoring and management of at-risk HBV-infected patients when offering antiviral therapy and monitoring after clinical cure of hepatitis B.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102627"},"PeriodicalIF":2.6,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of article types of the top-100 cited articles on gastrointestinal endoscopy 胃肠道内窥镜前100名被引文章类型分析。
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-26 DOI: 10.1016/j.clinre.2025.102630
Yanqing Song , Lei Deng , Yanhua Peng , Rui Zhou
{"title":"Analysis of article types of the top-100 cited articles on gastrointestinal endoscopy","authors":"Yanqing Song ,&nbsp;Lei Deng ,&nbsp;Yanhua Peng ,&nbsp;Rui Zhou","doi":"10.1016/j.clinre.2025.102630","DOIUrl":"10.1016/j.clinre.2025.102630","url":null,"abstract":"","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102630"},"PeriodicalIF":2.6,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natalizumab-induced autoimmune liver injury natalizumab诱导的自身免疫性肝损伤
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-23 DOI: 10.1016/j.clinre.2025.102624
Jeanete Sharay Rodriguez-Martinez , Nancy Haydee Serrano-Perez , Guillermo Espinosa-Zarazua , Jacqueline Cordova-Gallardo
{"title":"Natalizumab-induced autoimmune liver injury","authors":"Jeanete Sharay Rodriguez-Martinez ,&nbsp;Nancy Haydee Serrano-Perez ,&nbsp;Guillermo Espinosa-Zarazua ,&nbsp;Jacqueline Cordova-Gallardo","doi":"10.1016/j.clinre.2025.102624","DOIUrl":"10.1016/j.clinre.2025.102624","url":null,"abstract":"","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102624"},"PeriodicalIF":2.6,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis 一系列镰状细胞病相关的炎症性肠病:结肠累及和原发性硬化性胆管炎的高患病率
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-23 DOI: 10.1016/j.clinre.2025.102615
Julien Kirchgesner , Jeremy Augustin , Thomas Bazin , Pamela Freiha , Alexandre Nuzzo , Philippe Seksik , Iradj Sobhani , Pablo Bartolucci , Mathieu Uzzan
{"title":"A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis","authors":"Julien Kirchgesner ,&nbsp;Jeremy Augustin ,&nbsp;Thomas Bazin ,&nbsp;Pamela Freiha ,&nbsp;Alexandre Nuzzo ,&nbsp;Philippe Seksik ,&nbsp;Iradj Sobhani ,&nbsp;Pablo Bartolucci ,&nbsp;Mathieu Uzzan","doi":"10.1016/j.clinre.2025.102615","DOIUrl":"10.1016/j.clinre.2025.102615","url":null,"abstract":"<div><h3>Objective</h3><div>Co-occurrence of Sickle Cell Disease (SCD) and Inflammatory Bowel Diseases (IBD) has been scarcely reported. Our aim was to explore the intersection between SCD and IBD, focusing on the impact of SCD on the natural course of IBD and drug safety.</div></div><div><h3>Methods</h3><div>We conducted a multicenter retrospective case-control study including consecutive patients diagnosed with IBD and SCD. Each IBD patient with SCD was matched with up to 4 IBD patients without SCD. Matching criteria were IBD type, sex, date of birth, length of follow-up and year of diagnosis. The primary outcome was a complicated IBD course.</div></div><div><h3>Results</h3><div>125 IBD patients were studied, including 24 SCD. 23/24 SCD patients had colonic involvement. 33.3 % had concomitant primary sclerosing cholangitis (PSC) compared to 1 % of controls (<em>p</em> &lt; 0.001). Survival without a complicated IBD course was estimated at 58.7 % (CI95[49.6–69.5]) at 5 years for non-SCD patients, as compared to 63.3 % (CI95[45.7–87.6]) for SCD patients SCD (<em>p</em> = 0.36). The survival without the need of advanced therapy was estimated at 66.1 % (CI95[57.3–76.2]) at 5 years for non-SCD patient, and at 78.2 % (CI95[63–97.2]) in SCD patients (<em>p</em> = 0.45) Regarding treatment safety, 26.3 % of patients with SCD and 13.5 % of controls experienced adverse events with biologics (<em>p</em> = 0.17). There was one reported vaso-occlusive crisis associated with thiopurines.</div></div><div><h3>Conclusion</h3><div>Patients with SCD and IBD displayed a distinctive phenotype with constant colonic involvement and high prevalence of PSC.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102615"},"PeriodicalIF":2.6,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analgesics use and risk of pancreatitis: Result from the UK Biobank 镇痛药的使用和胰腺炎的风险:来自英国生物银行的结果。
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-20 DOI: 10.1016/j.clinre.2025.102616
Jiayi Wang , Wanxin Long , Zehong Qi , Yangjie Liao , Jingbo Li
{"title":"Analgesics use and risk of pancreatitis: Result from the UK Biobank","authors":"Jiayi Wang ,&nbsp;Wanxin Long ,&nbsp;Zehong Qi ,&nbsp;Yangjie Liao ,&nbsp;Jingbo Li","doi":"10.1016/j.clinre.2025.102616","DOIUrl":"10.1016/j.clinre.2025.102616","url":null,"abstract":"<div><h3>Background</h3><div>Pancreatitis, an inflammatory pancreatic disorder, arises from various etiologies including alcohol, tobacco, and drug use. Although the initiation of pancreatitis has been strongly linked to several medications, the association between analgesic use and pancreatitis risk remains ambiguous in population-based studies.</div></div><div><h3>Methods</h3><div>This prospective cohort study involved 324,982 participants from the UK Biobank. Multivariable-adjusted Cox proportional hazards models were conducted to evaluate the longitudinal association between incident pancreatitis risk and analgesics use, encompassing opioids, non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol, antimigraine preparations, and the mix. Subgroup and sensitivity analyses were conducted to assess the potential effects of baseline factors.</div></div><div><h3>Results</h3><div>Over a median follow-up of 13.70 years, 2303 cases of pancreatitis were identified. In the fully adjusted model, analgesics utilization increased the risk of pancreatitis (HR 1.13, 95 % CI 1.04–1.23), acute pancreatitis (AP) (HR 1.11, 95 % CI 1.01–1.22), and chronic pancreatitis (CP) (HR 1.25, 95 % CI 1.00–1.56) (All the above <em>p</em> &lt; 0.05). Furthermore, participants who used opioids presented the highest risk of pancreatitis (HR 1.85, 95 % CI 1.49–2.31, <em>p</em> &lt; 0.001), and the mixed group (HR 1.35, 95 % CI 1.21–1.51, <em>p</em> &lt; 0.001) followed. Compared to the non-analgesics group, the risk of both AP and CP also increased in the opioids and the mixed group. Subgroup analysis indicated that the impact of analgesics utilization on the pancreatitis risk may vary with certain covariates, such as age, cholelithiasis, etc. (p-interaction &lt;0.05).</div></div><div><h3>Conclusion</h3><div>In this large population-based prospective cohort, analgesics utilization, particularly opioids and mixed analgesics, was linked to an increased risk of pancreatitis.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102616"},"PeriodicalIF":2.6,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144126771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natalizumab-induced autoimmune liver injury natalizumab诱导的自身免疫性肝损伤
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-19 DOI: 10.1016/j.clinre.2025.102618
Jeanete Sharay Rodriguez-Martinez , Nancy Haydee Serrano-Perez , Guillermo Espinosa-Zarazua , Jacqueline Cordova-Gallardo
{"title":"Natalizumab-induced autoimmune liver injury","authors":"Jeanete Sharay Rodriguez-Martinez ,&nbsp;Nancy Haydee Serrano-Perez ,&nbsp;Guillermo Espinosa-Zarazua ,&nbsp;Jacqueline Cordova-Gallardo","doi":"10.1016/j.clinre.2025.102618","DOIUrl":"10.1016/j.clinre.2025.102618","url":null,"abstract":"","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 7","pages":"Article 102618"},"PeriodicalIF":2.6,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision oncology in colorectal cancer: An anatomical revolution through molecular-clinical integration across colonic subsites 结直肠癌的精确肿瘤学:通过结肠亚位分子-临床整合的解剖学革命
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-13 DOI: 10.1016/j.clinre.2025.102613
Jiefeng Zhao, Daxing Miao
{"title":"Precision oncology in colorectal cancer: An anatomical revolution through molecular-clinical integration across colonic subsites","authors":"Jiefeng Zhao,&nbsp;Daxing Miao","doi":"10.1016/j.clinre.2025.102613","DOIUrl":"10.1016/j.clinre.2025.102613","url":null,"abstract":"<div><div>Colorectal cancer (CRC) exhibits significant heterogeneity across different colonic subsites, which vary in embryological origin, microbiome, metabolome, and molecular profiles, affecting tumorigenesis, treatment response, and prognosis. We emphasize the importance of this subsite heterogeneity to advance precision medicine in CRC.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 6","pages":"Article 102613"},"PeriodicalIF":2.6,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144070639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A wandering spleen 流浪脾
IF 2.6 4区 医学
Clinics and research in hepatology and gastroenterology Pub Date : 2025-05-12 DOI: 10.1016/j.clinre.2025.102614
Francesco Guerra, Francesco Matarazzo, Giuseppe Giuliani, Andrea Coratti
{"title":"A wandering spleen","authors":"Francesco Guerra,&nbsp;Francesco Matarazzo,&nbsp;Giuseppe Giuliani,&nbsp;Andrea Coratti","doi":"10.1016/j.clinre.2025.102614","DOIUrl":"10.1016/j.clinre.2025.102614","url":null,"abstract":"","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 6","pages":"Article 102614"},"PeriodicalIF":2.6,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144068425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信